panipenem-betamipron

07/01/2012 - "Intravenous panipenem-betamipron is effective in treating moderate to severe pulmonary infection with low adverse events rate."
04/01/1992 - "4. The results above show that PAPM/BP is useful for the treatment of general infections in pediatrics and that a daily dose of about 60 mg/kg given in 3 divided doses in effective enough.(ABSTRACT TRUNCATED AT 250 WORDS)"
07/01/2001 - "PAPM/BP showed the greatest efficacy against the infections among tested drugs. "
01/01/1998 - "Yamagata Study Group of Panipenem/Betamipron in Obstetric and Gynecological Infections]."
07/01/2012 - "Among the enrolled 665 patients, 621 patients with moderate to severe pulmonary infection were treated with intravenous panipenem-betamipron at a dose of 500 mg every 6 hours per day for 7 - 14 days. "

07/01/2000 - "The pneumonia was improved by administration of PAPM/BP. On bronchoscopic examination, the trachea and main bronchi were extremely dilated on inspiration, and were collapsed on expiration. "
11/01/2004 - "A 64-year-old man was referred to us because of pneumonia refractory to panipenem/betamipron. "
06/01/2002 - "Forty-three episodes of pneumonia in 43 patients were treated with PAPM/BP as the sole antibiotic agent. "
07/01/2001 - "With the suspicion of pneumonia, the antibiotics were exchanged for panipenem/betamipron. "
03/01/1992 - "3. PAPM/BP was administered to 18 cases (upper and lower respiratory tract infections, pneumonia and urinary tract infections) at daily doses of 30-88.9 mg/kg/day divided into 3 dosages using 30-minute intravenous drip infusion. "

01/01/1999 - "From the above evaluation, we consider PAPM/BP to be an effective drug for normal adult patients as well as elderly patients of respiratory infections."
02/01/1992 - "[A clinical study on panipenem/betamipron in chronic respiratory tract infections]."
02/01/1992 - "In conclusion, PAPM/BP is a very useful parenteral antibiotic against respiratory tract infections and can be one of the drugs of the first choice."
04/01/1992 - "2. Clinical studies 10 mg/kg of PAPM/BP was administered intravenously 3 times a day to 18 cases including 15 of respiratory infections, 2 of otitis media and 1 of sepsis. "
03/01/1992 - "3. PAPM/BP was administered to 18 cases (upper and lower respiratory tract infections, pneumonia and urinary tract infections) at daily doses of 30-88.9 mg/kg/day divided into 3 dosages using 30-minute intravenous drip infusion. "

01/01/2003 - "Panipenem/betamipron was also effective in adults with surgical or gynaecological infections, and in paediatric patients with respiratory tract and urinary tract infections in noncomparative trials. "
01/01/2003 - "In large, randomised clinical trials, panipenem/betamipron demonstrated good clinical and bacteriological efficacy (similar to that of imipenem/cilastatin) in adults with respiratory tract or urinary tract infections. "
03/01/1992 - "Even 2 patients with purulent meningitis were treated with PAPM/BP at dose levels of no less than 20 mg/kg x 3 and 33 mg/kg x 3. Most of respiratory and urinary tract infection cases of moderate severities were treated at dose levels of 30-60 mg/kg/day, i.e., 10 mg/kg x 3 or 20 mg/kg x 3. No adverse reaction was observed. "
03/01/1992 - "3. PAPM/BP was administered to 18 cases (upper and lower respiratory tract infections, pneumonia and urinary tract infections) at daily doses of 30-88.9 mg/kg/day divided into 3 dosages using 30-minute intravenous drip infusion. "
01/01/2003 - "In small trials in elderly patients reported as abstracts, panipenem/betamipron demonstrated clinical efficacy similar to intravenous piperacillin and greater than oral ofloxacin in urinary tract infections. "

08/01/1997 - "We changed ABPC to PAPM/BP and the bacterial meningitis improved dramatically. "
08/01/2004 - "Although panipenem-betamipron, which is commercially available only in Japan, is recommended for treatment of pediatric bacterial meningitis by some experts, only a limited number of clinical studies have been reported. "
03/01/2004 - "We emphasize the importance of initial therapy with PAPM/BP and VCM in patients with bacterial meningitis from streptcoccus pneumoniae."
09/01/1995 - "We assume that panipenem/betamipron is recommended to be added to empiric therapy of bacterial meningitis, considering an increasing incidence of PRSP infection."